SCL Science Inc. (KOSDAQ:246960)

SCL Science Statistics

Total Valuation

SCL Science has a market cap or net worth of KRW 86.63 billion. The enterprise value is 99.86 billion.

Market Cap	86.63B
Enterprise Value	99.86B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SCL Science has 33.97 million shares outstanding. The number of shares has increased by 10.09% in one year.

Current Share Class	33.97M
Shares Outstanding	33.97M
Shares Change (YoY)	+10.09%
Shares Change (QoQ)	+16.09%
Owned by Insiders (%)	5.63%
Owned by Institutions (%)	n/a
Float	14.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.26
PB Ratio	3.34
P/TBV Ratio	6.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.23
EV / Sales	10.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.55

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.93.

Current Ratio	2.23
Quick Ratio	1.76
Debt / Equity	0.93
Debt / EBITDA	n/a
Debt / FCF	-3.27
Interest Coverage	-5.72

Financial Efficiency

Return on equity (ROE) is -16.22% and return on invested capital (ROIC) is -8.42%.

Return on Equity (ROE)	-16.22%
Return on Assets (ROA)	-7.27%
Return on Invested Capital (ROIC)	-8.42%
Return on Capital Employed (ROCE)	-10.12%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	7.69

Taxes

Income Tax	-16.57M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.28% in the last 52 weeks. The beta is 0.57, so SCL Science's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+21.28%
50-Day Moving Average	2,612.10
200-Day Moving Average	2,437.48
Relative Strength Index (RSI)	47.78
Average Volume (20 Days)	122,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SCL Science had revenue of KRW 9.36 billion and -3.54 billion in losses. Loss per share was -116.58.

Revenue	9.36B
Gross Profit	1.47B
Operating Income	-4.87B
Pretax Income	-3.55B
Net Income	-3.54B
EBITDA	-3.05B
EBIT	-4.87B
Loss Per Share	-116.58

Balance Sheet

The company has 10.93 billion in cash and 24.14 billion in debt, giving a net cash position of -13.21 billion or -388.87 per share.

Cash & Cash Equivalents	10.93B
Total Debt	24.14B
Net Cash	-13.21B
Net Cash Per Share	-388.87
Equity (Book Value)	25.90B
Book Value Per Share	761.98
Working Capital	13.57B

Cash Flow

In the last 12 months, operating cash flow was -6.97 billion and capital expenditures -405.38 million, giving a free cash flow of -7.37 billion.

Operating Cash Flow	-6.97B
Capital Expenditures	-405.38M
Free Cash Flow	-7.37B
FCF Per Share	-217.00

Margins

Gross margin is 15.66%, with operating and profit margins of -51.98% and -37.80%.

Gross Margin	15.66%
Operating Margin	-51.98%
Pretax Margin	-37.98%
Profit Margin	-37.80%
EBITDA Margin	-32.63%
EBIT Margin	-51.98%
FCF Margin	n/a

Dividends & Yields

SCL Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.09%
Shareholder Yield	-10.09%
Earnings Yield	-4.08%
FCF Yield	-8.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 30, 2025. It was a forward split with a ratio of 4.

Last Split Date	Jun 30, 2025
Split Type	Forward
Split Ratio	4

Scores

SCL Science has an Altman Z-Score of 0.4 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.4
Piotroski F-Score	1